MESO
Mesoblast Ltd
NASDAQ: MESO · HEALTHCARE · BIOTECHNOLOGY
$15.55
+2.17% today
Updated 2026-04-29
Market cap
$2.01B
P/E ratio
—
P/S ratio
30.75x
EPS (TTM)
$-0.74
Dividend yield
—
52W range
$10 – $22
Volume
0.3M
Mesoblast Ltd (MESO) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |